| Primary |
| Glaucoma |
44.9% |
| Open Angle Glaucoma |
10.7% |
| Intraocular Pressure Increased |
9.8% |
| Hypertension |
6.5% |
| Ocular Hypertension |
6.3% |
| Product Used For Unknown Indication |
3.0% |
| Diabetes Mellitus |
2.1% |
| Intraocular Pressure Test |
2.1% |
| Dry Eye |
1.8% |
| Blood Pressure Increased |
1.2% |
| Bone Disorder |
1.2% |
| Chondropathy |
1.2% |
| Conjunctival Hyperaemia |
1.2% |
| Conjunctivitis |
1.2% |
| Migraine |
1.2% |
| Proctocolitis |
1.2% |
| Surgery |
1.2% |
| Ulcerative Keratitis |
1.2% |
| Uveitis |
1.2% |
| Angle Closure Glaucoma |
0.9% |
|
| Ocular Hyperaemia |
7.9% |
| Vision Blurred |
7.9% |
| Corneal Deposits |
6.9% |
| Corneal Epithelium Defect |
6.9% |
| Skin Exfoliation |
6.9% |
| Drug Ineffective |
5.0% |
| Intraocular Pressure Increased |
5.0% |
| Joint Dislocation |
5.0% |
| Visual Field Defect |
5.0% |
| Vitreous Haemorrhage |
5.0% |
| Vocal Cord Paralysis |
5.0% |
| Death |
4.0% |
| Dizziness |
4.0% |
| Keratopathy |
4.0% |
| Myocardial Infarction |
4.0% |
| Ophthalmoplegia |
4.0% |
| Respiratory Rate Decreased |
4.0% |
| Visual Impairment |
4.0% |
| Hyperventilation |
3.0% |
| Loss Of Consciousness |
3.0% |
|
| Secondary |
| Glaucoma |
39.8% |
| Intraocular Pressure Increased |
14.4% |
| Energy Increased |
7.7% |
| Open Angle Glaucoma |
6.1% |
| Drug Use For Unknown Indication |
3.9% |
| Hypertonia |
3.3% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Pain |
2.8% |
| Angle Closure Glaucoma |
2.2% |
| Developmental Glaucoma |
2.2% |
| Hypertension |
2.2% |
| Uveitis |
2.2% |
| Corneal Graft Rejection |
1.7% |
| Endothelial Dysfunction |
1.7% |
| Osteoporosis |
1.7% |
| Anterior Chamber Disorder |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Choroidal Detachment |
1.1% |
| Diabetes Mellitus |
1.1% |
| Diuretic Therapy |
1.1% |
|
| Visual Acuity Reduced |
24.5% |
| Oesophageal Carcinoma |
7.5% |
| Photopsia |
7.5% |
| Corneal Epithelium Defect |
5.7% |
| Drug Hypersensitivity |
5.7% |
| Ocular Hyperaemia |
5.7% |
| Visual Impairment |
5.7% |
| Corneal Oedema |
3.8% |
| Dermatitis |
3.8% |
| Drug Ineffective |
3.8% |
| Eye Irritation |
3.8% |
| Intraocular Pressure Fluctuation |
3.8% |
| Paralysis |
3.8% |
| Visual Field Defect |
3.8% |
| Corneal Deposits |
1.9% |
| Dermatitis Contact |
1.9% |
| Dizziness |
1.9% |
| Drug Dispensing Error |
1.9% |
| Erythema |
1.9% |
| Eye Injury |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.4% |
| Glaucoma |
17.4% |
| Type 2 Diabetes Mellitus |
11.1% |
| Product Used For Unknown Indication |
10.9% |
| Hypertension |
6.1% |
| Diabetes Mellitus |
3.1% |
| Prophylaxis |
2.9% |
| Osteoporosis |
2.6% |
| Pain |
2.6% |
| Insomnia |
2.4% |
| Blood Cholesterol Increased |
2.2% |
| Arthritis |
2.1% |
| Depression |
2.1% |
| Multiple Myeloma |
2.1% |
| Atrial Fibrillation |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Intraocular Lens Implant |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Metastases To Bone |
1.5% |
|
| Renal Impairment |
8.9% |
| Vomiting |
7.2% |
| Somnolence |
6.7% |
| Visual Acuity Reduced |
6.7% |
| Weight Decreased |
6.7% |
| Intraocular Pressure Increased |
5.6% |
| Vision Blurred |
5.6% |
| Pyrexia |
5.0% |
| Thrombocytopenia |
5.0% |
| Glaucoma |
4.4% |
| Headache |
4.4% |
| Type 2 Diabetes Mellitus |
4.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.9% |
| Myocardial Infarction |
3.9% |
| Pulmonary Embolism |
3.9% |
| Toxic Anterior Segment Syndrome |
3.9% |
| Toxic Skin Eruption |
3.9% |
| Nausea |
3.3% |
| Ocular Hyperaemia |
3.3% |
| Renal Failure Chronic |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Glaucoma |
33.3% |
| Dementia Alzheimer's Type |
16.7% |
|
| Drug Interaction |
50.0% |
| Vision Blurred |
50.0% |
|
